2025-11-07

#reports #YELP

[Yelp](https://eninvs.com/all.php?name=YELP) (Crowdsourcing platform) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +4.4% YoY (vs +3.6% in previous quarter and historical rate +8.3%)
- EBITDA +18.2% YoY (vs +34.7% in previous quarter and historical rate +56.1%)
- EBITDA margin 20.7% increased compared to 18.3% same period last year
- Net Debt decreased by $35 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 20.8x
- EV/Sales multiple is 1.2x

------------------------------------------------

2025-11-07

#reports #XRAY

[DENTSPLY SIRONA](https://eninvs.com/all.php?name=XRAY) (Dental materials and equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193370)
(2025-11-06, Before Market Open):

- Revenue -4.9% YoY (vs -4.9% in previous quarter and historical rate +4.6%)
- EBITDA margin -16.4% increased compared to -45.1% same period last year
- Net Debt decreased by $26 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 5.7% of market cap
- EV/Sales multiple is 0.8x

At the opening of the session the share price went down -10.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #XPOF

[Xponential Fitness, Inc.](https://eninvs.com/all.php?name=XPOF) (Leisure) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -1.2% YoY (vs -1.3% in previous quarter and historical rate +13.8%)
- EBITDA margin 8.9% increased compared to -2.5% same period last year
- Net Debt decreased by $75 mln over the past reporting period (34.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 36.3% of market cap
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-11-07

#reports #WSC

[WillScot](https://eninvs.com/all.php?name=WSC) (Warehouse service provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193366)
(2025-11-06, After Market Close):

- Revenue -5.7% YoY (vs -2.6% in previous quarter and historical rate +1.8%)
- EBITDA +392.7% YoY (vs +207.1% in previous quarter and historical rate +22.6%)
- EBITDA margin 35.6% increased compared to 6.8% same period last year
- Net Debt decreased by $52 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 8.7x compared to historical level (75th percentile) of 15.1x
- EV/Sales multiple is 3.2x

------------------------------------------------

2025-11-07

#reports #WRBY

[Warby Parker Inc.](https://eninvs.com/all.php?name=WRBY) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193365)
(2025-11-06, Before Market Open):

- Revenue +15.6% YoY (vs +13.8% in previous quarter and historical rate +13.3%)
- EBITDA +333.3% YoY (vs -600.0% in previous quarter and historical rate +83.3%)
- EBITDA margin 5.9% increased compared to 1.6% same period last year
- Net Debt increased by $10 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 67.6x compared to historical level (75th percentile) of 306x
- EV/Sales multiple is 2.4x

At the opening of the session the share price went up +2.1% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #VTRS

[Viatris](https://eninvs.com/all.php?name=VTRS) (Medicines manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193362)
(2025-11-06, Before Market Open):

- Revenue +0.2% YoY (vs -5.7% in previous quarter and historical rate -5.4%)
- EBITDA -20.9% YoY (vs +73.4% in previous quarter and historical rate -22.0%)
- EBITDA margin 11.5% decreased compared to 14.6% same period last year
- Net Debt decreased by $442 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) -$0.5 bln (negative), 3.9% of market cap
- EV/EBITDA multiple is 145.4x compared to historical level (75th percentile) of 11.6x
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-11-07

#reports #VHI

[Valhi](https://eninvs.com/all.php?name=VHI) (Chemicals) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193361)
(2025-11-06, After Market Close):

- Revenue +8% YoY (vs -1.4% in previous quarter and historical rate -3.6%)
- EBITDA -60.7% YoY (vs -55.0% in previous quarter and historical rate +37.0%)
- EBITDA margin 4.6% decreased compared to 12.6% same period last year
- Net Debt increased by $28 mln over the past reporting period (7.4% of market cap)
- FCF (LTM) -$0.2 bln (negative), 43.1% of market cap
- EV/EBITDA multiple is 4x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-11-07

#reports #VERI

[Veritone](https://eninvs.com/all.php?name=VERI) (Software — Infrastructure) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +31.8% YoY (vs -22.6% in previous quarter and historical rate -12.9%)
- EBITDA margin -27.6% increased compared to -68.2% same period last year
- Net Debt decreased by $23 mln over the past reporting period (7.3% of market cap)
- FCF (LTM) +$0 bln (positive), 8.5% of market cap
- EV/Sales multiple is 4.1x

------------------------------------------------

2025-11-07

#reports #VCEL

[Vericel](https://eninvs.com/all.php?name=VCEL) (Medical services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193360)
(2025-11-06, Before Market Open):

- Revenue +17.2% YoY (vs +18.9% in previous quarter and historical rate +17.5%)
- EBITDA margin 8.8% increased compared to -1.7% same period last year
- Net Debt decreased by $20 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 132.6x compared to historical level (75th percentile) of 747.3x
- EV/Sales multiple is 7.2x

At the opening of the session the share price went up +11.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #URGN

[UroGen Pharma](https://eninvs.com/all.php?name=URGN) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193358)
(2025-11-06, Before Market Open):

- Revenue +8% YoY (vs +9.1% in previous quarter and historical rate +15.3%)
- EBITDA margin -100.0% decreased compared to -68.0% same period last year
- Net Debt increased by $32 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 8.6% of market cap
- EV/Sales multiple is 11.7x

At the opening of the session the share price went down -5.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #UPLD

[Upland Software](https://eninvs.com/all.php?name=UPLD) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193357)
(2025-11-06, Before Market Open):

- Revenue -23.9% YoY (vs -23.2% in previous quarter and historical rate -9.1%)
- EBITDA +7.1% YoY (vs -72.7% in previous quarter)
- EBITDA margin 29.4% increased compared to 20.9% same period last year
- Net Debt decreased by $35 mln over the past reporting period (66.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 314.4% of market cap
- EV/EBITDA multiple is 18.3x compared to historical level (75th percentile) of 68.9x
- EV/Sales multiple is 3.4x

At the opening of the session the share price went up +1.6% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #UEIC

[Universal Electronics](https://eninvs.com/all.php?name=UEIC) ( Innovative products manufacturer) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -10.8% YoY (vs +8.9% in previous quarter and historical rate -10.8%)
- EBITDA -120% YoY (vs 0.0% in previous quarter)
- EBITDA margin -1.1% decreased compared to 4.9% same period last year
- Net Debt decreased by $10 mln over the past reporting period (22.8% of market cap)
- FCF (LTM) +$0 bln (positive), 43.4% of market cap
- EV/Sales multiple is 0.1x

------------------------------------------------

2025-11-07

#reports #TXG

[10X Genomics](https://eninvs.com/all.php?name=TXG) (Medical services provider) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -2% YoY (vs +13.1% in previous quarter and historical rate +9.0%)
- EBITDA margin -17.4% increased compared to -23.0% same period last year
- Net Debt decreased by $34 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0 bln (positive), 3.3% of market cap
- EV/Sales multiple is 1.7x

------------------------------------------------

2025-11-07

#reports #TTEC

[TTEC](https://eninvs.com/all.php?name=TTEC) (IT services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193354)
(2025-11-06, After Market Close):

- Revenue -1.9% YoY (vs -3.7% in previous quarter and historical rate -3.6%)
- EBITDA -7.9% YoY (vs +4100.0% in previous quarter and historical rate -12.9%)
- EBITDA margin 6.7% decreased compared to 7.2% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 87.2% of market cap
- EV/EBITDA multiple is 6.6x compared to historical level (75th percentile) of 9.2x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-11-07

#reports #TRIP

[TripAdvisor](https://eninvs.com/all.php?name=TRIP) (Travel services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193351)
(2025-11-06, Before Market Open):

- Revenue +3.9% YoY (vs +6.4% in previous quarter and historical rate +13.1%)
- EBITDA +3.3% YoY (vs +46.4% in previous quarter and historical rate +10.0%)
- EBITDA margin 17.0% decreased compared to 17.1% same period last year
- Net Debt decreased by $11 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.3 bln (negative), 13.7% of market cap
- EV/EBITDA multiple is 10.7x compared to historical level (75th percentile) of 14.5x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +6.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TPR

[Tapestry](https://eninvs.com/all.php?name=TPR) (Clothes seller) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193349)
(2025-11-06, Before Market Open):

- Revenue +13.1% YoY (vs -74.2% in previous quarter and historical rate +6.6%)
- EBITDA +25.9% YoY (vs -62.3% in previous quarter and historical rate +8.4%)
- EBITDA margin 21.6% increased compared to 19.4% same period last year
- Net Debt increased by $676 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 19.5x compared to historical level (75th percentile) of 8.6x
- EV/Sales multiple is 4.8x

At the opening of the session the share price went down -13.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TNDM

[Tandem Diabetes Care](https://eninvs.com/all.php?name=TNDM) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193348)
(2025-11-06, After Market Close):

- Revenue +2% YoY (vs +8.6% in previous quarter and historical rate +9.4%)
- EBITDA margin -8.0% increased compared to -9.4% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 15.3% of market cap
- EV/Sales multiple is 1x

------------------------------------------------

2025-11-07

#reports #TMCI

[Treace Medical Concepts, Inc.](https://eninvs.com/all.php?name=TMCI) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193347)
(2025-11-06, After Market Close):

- Revenue +11.1% YoY (vs +6.8% in previous quarter and historical rate +21.1%)
- EBITDA margin -26.0% increased compared to -28.9% same period last year
- Net Debt increased by $11 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) -$0 bln (negative), 3.2% of market cap
- EV/Sales multiple is 1.6x

------------------------------------------------

2025-11-07

#reports #TKNO

[Alpha Teknova, Inc.](https://eninvs.com/all.php?name=TKNO) (Drug Manufacturers — Specialty and Generic) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -2.8%)
- EBITDA margin -40.0% increased compared to -70.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.2% of market cap
- EV/Sales multiple is 3.6x

------------------------------------------------

2025-11-07

#reports #THR

[Thermon Group](https://eninvs.com/all.php?name=THR) (Specialty Industrial Machinery) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193346)
(2025-11-06, Before Market Open):

- Revenue 0% YoY (vs -5.2% in previous quarter and historical rate +7.6%)
- EBITDA 0% YoY (vs -10.5% in previous quarter and historical rate +10.4%)
- EBITDA margin 18.3% has not changed compared to 18.3% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 13.1x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went up +8.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TH

[Target Hospitality](https://eninvs.com/all.php?name=TH) (Oil and Gas Equipment and Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193345)
(2025-11-06, Before Market Open):

- Revenue +4.2% YoY (vs -38.6% in previous quarter and historical rate -1.6%)
- EBITDA -53.1% YoY (vs -106.7% in previous quarter and historical rate -5.4%)
- EBITDA margin 15.2% decreased compared to 33.7% same period last year
- Net Debt decreased by $36 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 26.8% of market cap
- EV/EBITDA multiple is 12.6x compared to historical level (75th percentile) of 6.9x
- EV/Sales multiple is 2x

At the opening of the session the share price went up +3.6% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TGLS

[Tecnoglass](https://eninvs.com/all.php?name=TGLS) (Building Materials) reported for 2025 q3
(2025-11-06, Before Market Open):

- Revenue +9.2% YoY (vs +16.4% in previous quarter and historical rate +17.5%)
- EBITDA 0% YoY (vs +20.7% in previous quarter and historical rate +33.7%)
- EBITDA margin 28.8% decreased compared to 31.5% same period last year
- Net Debt increased by $17 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 8.6x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -2.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TFX

[Teleflex](https://eninvs.com/all.php?name=TFX) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193344)
(2025-11-06, Before Market Open):

- Revenue +19.5% YoY (vs +4.1% in previous quarter and historical rate +4.6%)
- EBITDA -328.2% YoY (vs +28.1% in previous quarter and historical rate -34.5%)
- EBITDA margin -42.5% decreased compared to 22.3% same period last year
- Net Debt increased by $685 mln over the past reporting period (14.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/Sales multiple is 2.3x

At the opening of the session the share price went down -3.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TCX

[Tucows](https://eninvs.com/all.php?name=TCX) (Domain name registrar) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193343)
(2025-11-06, After Market Close):

- Revenue +7.6% YoY (vs +10.1% in previous quarter and historical rate +6.0%)
- EBITDA margin 2.0% increased compared to -1.1% same period last year
- Net Debt increased by $13 mln over the past reporting period (6.3% of market cap)
- FCF (LTM) -$0.3 bln (negative), 162.6% of market cap
- EV/EBITDA multiple is 249.1x compared to historical level (75th percentile) of 41.1x
- EV/Sales multiple is 1.3x

------------------------------------------------

2025-11-07

#reports #STRA

[Strategic Education](https://eninvs.com/all.php?name=STRA) (Educational service provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193338)
(2025-11-06, Before Market Open):

- Revenue +4.6% YoY (vs +2.9% in previous quarter and historical rate +5.6%)
- EBITDA +29.8% YoY (vs +9.4% in previous quarter and historical rate +24.8%)
- EBITDA margin 19.1% increased compared to 15.4% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 15.6x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +5.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #SRTS

[Sensus Healthcare](https://eninvs.com/all.php?name=SRTS) (Medical Devices) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -22.2% YoY (vs -22.2% in previous quarter and historical rate +12.4%)
- EBITDA -200% YoY (vs -200.0% in previous quarter)
- EBITDA margin -28.6% decreased compared to 22.2% same period last year
- Net Debt decreased by $2 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) +$0 bln (positive), 7.0% of market cap
- EV/Sales multiple is 1x

------------------------------------------------

2025-11-07

#reports #SKIN

[The Beauty Health Company](https://eninvs.com/all.php?name=SKIN) (Special purpose acquisition company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193335)
(2025-11-06, After Market Close):

- Revenue -10.1% YoY (vs -14.3% in previous quarter and historical rate -3.1%)
- EBITDA margin -298.6% decreased compared to -287.3% same period last year
- Net Debt decreased by $5 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) +$0 bln (positive), 27.7% of market cap
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-11-07

#reports #SGHT

[Sight Sciences, Inc.](https://eninvs.com/all.php?name=SGHT) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193332)
(2025-11-06, After Market Close):

- Revenue 0% YoY (vs -4.8% in previous quarter and historical rate +19.9%)
- EBITDA margin -40.0% increased compared to -65.0% same period last year
- Net Debt increased by $10 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$0 bln (negative), 9.2% of market cap
- EV/Sales multiple is 2.4x

------------------------------------------------

2025-11-07

#reports #SG

[Sweetgreen, Inc.](https://eninvs.com/all.php?name=SG) (Restaurants) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -6.3% YoY (vs +0.5% in previous quarter and historical rate +42.0%)
- EBITDA margin -11.2% decreased compared to 0.3% same period last year
- Net Debt increased by $56 mln over the past reporting period (8.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 13.1% of market cap
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-11-07

#reports #SCSC

[ScanSource](https://eninvs.com/all.php?name=SCSC) (Scanner supplier) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193331)
(2025-11-06, Before Market Open):

- Revenue -4.6% YoY (vs +9.0% in previous quarter and historical rate +7.0%)
- EBITDA +28% YoY (vs +17.2% in previous quarter and historical rate +3.4%)
- EBITDA margin 4.3% increased compared to 3.2% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 9.2x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -10.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #RL

[Ralph Lauren](https://eninvs.com/all.php?name=RL) (Clothing and accessories manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193325)
(2025-11-06, Before Market Open):

- Revenue +16.5% YoY (vs +13.7% in previous quarter and historical rate +5.8%)
- EBITDA +28.9% YoY (vs +25.1% in previous quarter and historical rate +19.4%)
- EBITDA margin 15.1% increased compared to 13.6% same period last year
- Net Debt increased by $263 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.0% of market cap
- EV/EBITDA multiple is 17.2x compared to historical level (75th percentile) of 15.7x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +2.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #RGNX

[REGENXBIO](https://eninvs.com/all.php?name=RGNX) (Developer of viral gene therapy) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193324)
(2025-11-06, Before Market Open):

- Revenue +25% YoY (vs -4.5% in previous quarter and historical rate +2.2%)
- EBITDA margin -163.3% increased compared to -229.2% same period last year
- Net Debt increased by $48 mln over the past reporting period (8.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 13.0% of market cap
- EV/Sales multiple is 2.3x

At the opening of the session the share price went down -1.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #QNST

[QuinStreet](https://eninvs.com/all.php?name=QNST) (Marketing services provider ) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +2.5% YoY (vs +32.3% in previous quarter and historical rate +32.3%)
- EBITDA +120% YoY (vs +100.0% in previous quarter)
- EBITDA margin 3.8% increased compared to 1.8% same period last year
- EV/EBITDA multiple is 18.9x compared to historical level (75th percentile) of 713x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-11-07

#reports #PZZA

[Papa Johns International](https://eninvs.com/all.php?name=PZZA) (Owner of restaurants) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193322)
(2025-11-06, Before Market Open):

- Revenue +0.2% YoY (vs +4.1% in previous quarter and historical rate +10.0%)
- EBITDA -72.3% YoY (vs -6.5% in previous quarter and historical rate +20.3%)
- EBITDA margin 4.5% decreased compared to 16.4% same period last year
- Net Debt decreased by $22 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 15x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -3.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PRVA

[Privia Health Group, Inc.](https://eninvs.com/all.php?name=PRVA) (Health Information Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193318)
(2025-11-06, Before Market Open):

- Revenue +32.4% YoY (vs +23.5% in previous quarter and historical rate +17.6%)
- EBITDA +150% YoY (vs -14.3% in previous quarter and historical rate +99.9%)
- EBITDA margin 3.4% increased compared to 1.8% same period last year
- Net Debt decreased by $48 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 60.7x compared to historical level (75th percentile) of 107.9x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +5.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PRTH

[Priority Technology](https://eninvs.com/all.php?name=PRTH) (Software — Infrastructure) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193317)
(2025-11-06, Before Market Open):

- Revenue +6.2% YoY (vs +9.1% in previous quarter and historical rate +14.2%)
- EBITDA +2.8% YoY (vs +8.2% in previous quarter and historical rate +78.6%)
- EBITDA margin 76.3% decreased compared to 78.9% same period last year
- Net Debt increased by $82 mln over the past reporting period (21.4% of market cap)
- FCF (LTM) +$1.8 bln (positive), 462.1% of market cap
- EV/EBITDA multiple is 1.9x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went down -6.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PODD

[Insulet](https://eninvs.com/all.php?name=PODD) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193315)
(2025-11-06, Before Market Open):

- Revenue +29.8% YoY (vs +32.7% in previous quarter and historical rate +26.7%)
- EBITDA +31.3% YoY (vs +106.3% in previous quarter and historical rate +74.6%)
- EBITDA margin 20.8% increased compared to 20.6% same period last year
- Net Debt decreased by $21 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 45.8x compared to historical level (75th percentile) of 91.6x
- EV/Sales multiple is 9.1x

At the opening of the session the share price went up +3.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PLTK

[Playtika Holding Corp.](https://eninvs.com/all.php?name=PLTK) (Electronic Gaming and Multimedia) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193313)
(2025-11-06, Before Market Open):

- Revenue +8.7% YoY (vs +11.0% in previous quarter and historical rate +1.3%)
- EBITDA +0.8% YoY (vs -20.4% in previous quarter and historical rate -8.7%)
- EBITDA margin 19.3% decreased compared to 20.8% same period last year
- Net Debt decreased by $34 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0.6 bln (negative), 37.8% of market cap
- EV/EBITDA multiple is 8.7x compared to historical level (75th percentile) of 9x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +6.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PLNT

[Planet Fitness](https://eninvs.com/all.php?name=PLNT) ( Fitness centers owner) reported for 2025 q3
(2025-11-06, Before Market Open):

- Revenue +13% YoY (vs +13.3% in previous quarter and historical rate +16.1%)
- EBITDA +19.7% YoY (vs +11.0% in previous quarter and historical rate +48.5%)
- EBITDA margin 44.2% increased compared to 41.8% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 19.4x compared to historical level (75th percentile) of 22.8x
- EV/Sales multiple is 8.1x

At the opening of the session the share price went up +12.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PENN

[Penn National Gaming](https://eninvs.com/all.php?name=PENN) (Provider of entertainment services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193312)
(2025-11-06, Before Market Open):

- Revenue +4.8% YoY (vs +6.1% in previous quarter and historical rate +2.5%)
- EBITDA -476.1% YoY (vs +2.2% in previous quarter and historical rate -18.6%)
- EBITDA margin -38.6% decreased compared to 10.7% same period last year
- Net Debt increased by $100 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.5% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +9.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PDFS

[PDF Solutions](https://eninvs.com/all.php?name=PDFS) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193311)
(2025-11-06, After Market Close):

- Revenue +23.9% YoY (vs +23.8% in previous quarter and historical rate +15.2%)
- EBITDA +133.3% YoY (vs +200.0% in previous quarter)
- EBITDA margin 12.3% increased compared to 6.5% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 13.8% of market cap
- EV/EBITDA multiple is 222.8x compared to historical level (75th percentile) of 1057x
- EV/Sales multiple is 5.4x

------------------------------------------------

2025-11-07

#reports #PCRX

[Pacira BioSciences](https://eninvs.com/all.php?name=PCRX) (Medicines manufacturer) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +6.5% YoY (vs +1.7% in previous quarter and historical rate +3.2%)
- EBITDA margin 7.8% increased compared to -78.1% same period last year
- Net Debt decreased by $53 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 7.0% of market cap
- EV/EBITDA multiple is 14.2x compared to historical level (75th percentile) of 22.7x
- EV/Sales multiple is 1.7x

------------------------------------------------

2025-11-07

#reports #PBH

[Prestige Consumer Healthcare](https://eninvs.com/all.php?name=PBH) (Medicines manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193309)
(2025-11-06, Before Market Open):

- Revenue -3.5% YoY (vs -6.4% in previous quarter and historical rate +0.1%)
- EBITDA -5.4% YoY (vs -1.2% in previous quarter and historical rate 0.0%)
- EBITDA margin 31.8% decreased compared to 32.4% same period last year
- Net Debt increased by $19 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 11x compared to historical level (75th percentile) of 459.4x
- EV/Sales multiple is 3.6x

At the opening of the session the share price went up +2.1% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PAR

[PAR Technology Corporation](https://eninvs.com/all.php?name=PAR) (Restaurant software and hardware solutions provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193308)
(2025-11-06, After Market Close):

- Revenue +22.7% YoY (vs +43.6% in previous quarter and historical rate +10.3%)
- EBITDA margin -16.0% increased compared to -17.5% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0 bln (positive), 3.1% of market cap
- EV/Sales multiple is 3.7x

------------------------------------------------

2025-11-07

#reports #ORGO

[Organogenesis](https://eninvs.com/all.php?name=ORGO) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193305)
(2025-11-06, After Market Close):

- Revenue +31.3% YoY (vs -22.3% in previous quarter and historical rate +0.8%)
- EBITDA +150% YoY (vs -1000.0% in previous quarter)
- EBITDA margin 16.6% increased compared to 8.7% same period last year
- Net Debt increased by $61 mln over the past reporting period (11.9% of market cap)
- FCF (LTM) -$0.5 bln (negative), 106.4% of market cap
- EV/EBITDA multiple is 161.5x compared to historical level (75th percentile) of 97.6x
- EV/Sales multiple is 2.4x

------------------------------------------------

2025-11-07

#reports #OPEN

[Opendoor Technologies](https://eninvs.com/all.php?name=OPEN) (Real Estate Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193304)
(2025-11-06, After Market Close):

- Revenue -33.6% YoY (vs -70.6% in previous quarter and historical rate -16.0%)
- EBITDA -128.5% YoY (vs +800.0% in previous quarter and historical rate +7.0%)
- EBITDA margin -3.8% decreased compared to 8.9% same period last year
- Net Debt decreased by $344 mln over the past reporting period (7.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 132.8x compared to historical level (75th percentile) of 33.2x
- EV/Sales multiple is 1x

------------------------------------------------

2025-11-07

#reports #OLPX

[Olaplex Holdings, Inc.](https://eninvs.com/all.php?name=OLPX) (Specialty Retail) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193303)
(2025-11-06, Before Market Open):

- Revenue -3.4% YoY (vs +1.9% in previous quarter and historical rate -15.6%)
- EBITDA -77.4% YoY (vs -94.7% in previous quarter and historical rate -57.5%)
- EBITDA margin 6.1% decreased compared to 26.1% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 7.0% of market cap
- EV/EBITDA multiple is 32.7x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went up +4.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #OLED

[Universal Display](https://eninvs.com/all.php?name=OLED) (OLED research company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193302)
(2025-11-06, After Market Close):

- Revenue -13.6% YoY (vs +8.2% in previous quarter and historical rate +3.2%)
- EBITDA -23.7% YoY (vs +21.5% in previous quarter and historical rate +6.0%)
- EBITDA margin 41.4% decreased compared to 46.9% same period last year
- Net Debt decreased by $78 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 21x compared to historical level (75th percentile) of 27.3x
- EV/Sales multiple is 9.1x

------------------------------------------------

2025-11-07

#reports #NXST

[Nexstar Media](https://eninvs.com/all.php?name=NXST) (Media company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193301)
(2025-11-06, Before Market Open):

- Revenue -12.3% YoY (vs -3.2% in previous quarter and historical rate +1.6%)
- EBITDA -30.5% YoY (vs -8.5% in previous quarter and historical rate +1.0%)
- EBITDA margin 30.5% decreased compared to 38.4% same period last year
- Net Debt increased by $13 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.2% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 7.4x
- EV/Sales multiple is 2.6x

At the opening of the session the share price went down -4.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #NTRA

[Natera](https://eninvs.com/all.php?name=NTRA) (Medical services provider) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +34.5% YoY (vs +32.4% in previous quarter and historical rate +40.3%)
- EBITDA margin -15.0% decreased compared to -7.0% same period last year
- Net Debt decreased by $25 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.9% of market cap
- EV/Sales multiple is 8.8x

------------------------------------------------

2025-11-07

#reports #NTCT

[NetScout Systems](https://eninvs.com/all.php?name=NTCT) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193298)
(2025-11-06, Before Market Open):

- Revenue +14.7% YoY (vs +6.9% in previous quarter and historical rate -0.4%)
- EBITDA +69.2% YoY (vs +1300.0% in previous quarter and historical rate +14.5%)
- EBITDA margin 20.1% increased compared to 13.6% same period last year
- Net Debt increased by $18 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.2 bln (positive), 8.7% of market cap
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 11.5x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went up +9.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #NRG

[NRG Energy](https://eninvs.com/all.php?name=NRG) (Energy services provider) reported for 2025 q3
(2025-11-06, Before Market Open):

- Revenue +5.7% YoY (vs +1.2% in previous quarter and historical rate +3.1%)
- EBITDA margin 10.1% increased compared to -6.4% same period last year
- Net Debt increased by $884 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0.7 bln (negative), 1.7% of market cap
- EV/EBITDA multiple is 14.7x compared to historical level (75th percentile) of 13.2x
- EV/Sales multiple is 1.8x

At the opening of the session the share price went down -2.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #NEPH

[Nephros](https://eninvs.com/all.php?name=NEPH) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193294)
(2025-11-06, After Market Close):

- Revenue +25% YoY (vs +33.3% in previous quarter and historical rate +28.5%)
- EV/EBITDA multiple is 50.1x compared to historical level (75th percentile) of 40x
- EV/Sales multiple is 2.8x

------------------------------------------------

2025-11-07

#reports #MLAB

[Mesa Laboratories](https://eninvs.com/all.php?name=MLAB) (Electronic measuring instruments manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193291)
(2025-11-06, After Market Close):

- Revenue +5.2% YoY (vs +3.4% in previous quarter and historical rate +5.5%)
- EBITDA -50% YoY (vs -45.5% in previous quarter and historical rate +30.3%)
- EBITDA margin 9.8% decreased compared to 20.7% same period last year
- Net Debt decreased by $90 mln over the past reporting period (22.7% of market cap)
- FCF (LTM) -$0.2 bln (negative), 42.9% of market cap
- EV/EBITDA multiple is 20.9x compared to historical level (75th percentile) of 27.3x
- EV/Sales multiple is 2.6x

------------------------------------------------

2025-11-07

#reports #MCHP

[Microchip Technology](https://eninvs.com/all.php?name=MCHP) (Semiconductor products manufacturer) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -2.1% YoY (vs -13.3% in previous quarter and historical rate -14.0%)
- EBITDA -39.3% YoY (vs -42.3% in previous quarter and historical rate -27.6%)
- EBITDA margin 19.5% decreased compared to 31.4% same period last year
- Net Debt increased by $247 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$1.2 bln (positive), 3.8% of market cap
- EV/EBITDA multiple is 40.9x compared to historical level (75th percentile) of 19.4x
- EV/Sales multiple is 9x

------------------------------------------------

2025-11-07

#reports #LSPD

[Lightspeed POS](https://eninvs.com/all.php?name=LSPD) (Software provider) reported for 2025 q3
(2025-11-06, Before Market Open):

- Revenue +15.2% YoY (vs +14.7% in previous quarter and historical rate +20.8%)
- EBITDA margin -11.0% increased compared to -13.0% same period last year
- Net Debt decreased by $14 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 5.4% of market cap
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +7.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #LNTH

[Lantheus](https://eninvs.com/all.php?name=LNTH) (Medicine equipment developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193286)
(2025-11-06, Before Market Open):

- Revenue +1.3% YoY (vs -4.1% in previous quarter and historical rate +27.6%)
- EBITDA -56.8% YoY (vs -5.0% in previous quarter and historical rate +29.4%)
- EBITDA margin 16.7% decreased compared to 39.1% same period last year
- Net Debt increased by $315 mln over the past reporting period (8.5% of market cap)
- FCF (LTM) -$0.2 bln (negative), 4.7% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 47x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went up +6.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #LMAT

[LeMaitre Vascular](https://eninvs.com/all.php?name=LMAT) (Medical equipment manufacturer) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +10.9% YoY (vs +14.3% in previous quarter and historical rate +14.5%)
- EBITDA +43.8% YoY (vs +11.8% in previous quarter and historical rate +27.3%)
- EBITDA margin 37.7% increased compared to 29.1% same period last year
- Net Debt decreased by $23 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 24.7x compared to historical level (75th percentile) of 34.3x
- EV/Sales multiple is 7.4x

------------------------------------------------

2025-11-07

#reports #LGND

[Ligand Pharmaceuticals](https://eninvs.com/all.php?name=LGND) (Medicines manufacturer) reported for 2025 q3
(2025-11-06, Before Market Open):

- Revenue +121.2% YoY (vs +14.3% in previous quarter and historical rate +11.7%)
- EBITDA margin 14.8% increased compared to 1.9% same period last year
- Net Debt increased by $34 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 822x compared to historical level (75th percentile) of 255.1x
- EV/Sales multiple is 13.1x

At the opening of the session the share price went up +3.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #LFST

[LifeStance Health Group, Inc.](https://eninvs.com/all.php?name=LFST) (Medical Care Facilities) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193285)
(2025-11-06, Before Market Open):

- Revenue +16.3% YoY (vs +10.6% in previous quarter and historical rate +13.4%)
- EBITDA +40% YoY (vs +266.7% in previous quarter and historical rate +99.2%)
- EBITDA margin 5.8% increased compared to 4.8% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.6% of market cap
- EV/EBITDA multiple is 42.4x compared to historical level (75th percentile) of 216.2x
- EV/Sales multiple is 2x

At the opening of the session the share price went up +11.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #LCUT

[Lifetime Brands](https://eninvs.com/all.php?name=LCUT) (Furnishings, Fixtures and Appliances) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193284)
(2025-11-06, Before Market Open):

- Revenue -6.5% YoY (vs -7.0% in previous quarter and historical rate -5.0%)
- EBITDA +15.4% YoY (vs -420.0% in previous quarter and historical rate +40.9%)
- EBITDA margin 8.7% increased compared to 7.1% same period last year
- Net Debt increased by $19 mln over the past reporting period (28.9% of market cap)
- FCF (LTM) +$0 bln (positive), 66.9% of market cap
- EV/EBITDA multiple is 22.2x compared to historical level (75th percentile) of 23.1x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -5.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #LASR

[nLight](https://eninvs.com/all.php?name=LASR) (Semiconductor laser products manufacturer) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +19.6% YoY (vs +21.6% in previous quarter and historical rate -2.6%)
- EBITDA margin -1.5% increased compared to -14.3% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/Sales multiple is 6.1x

------------------------------------------------

2025-11-07

#reports #KVHI

[KVH Industries](https://eninvs.com/all.php?name=KVHI) (Communication Equipment) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193281)
(2025-11-06, Before Market Open):

- Revenue -3.4% YoY (vs -6.9% in previous quarter and historical rate -12.5%)
- EBITDA -35.3% YoY (vs +100.0% in previous quarter)
- EBITDA margin 39.3% decreased compared to 58.6% same period last year
- Net Debt decreased by $13 mln over the past reporting period (11.9% of market cap)
- FCF (LTM) +$0 bln (positive), 5.5% of market cap
- EV/EBITDA multiple is 5.2x compared to historical level (75th percentile) of 8x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -4.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #KRO

[Kronos Worldwide](https://eninvs.com/all.php?name=KRO) (Specialty Chemicals) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193279)
(2025-11-06, After Market Close):

- Revenue -5.8% YoY (vs -1.4% in previous quarter and historical rate -2.1%)
- EBITDA -106.7% YoY (vs -52.1% in previous quarter and historical rate +37.2%)
- EBITDA margin -0.9% decreased compared to 12.4% same period last year
- Net Debt increased by $27 mln over the past reporting period (5.0% of market cap)
- FCF (LTM) -$0.2 bln (negative), 35.6% of market cap
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 22.5x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-11-07

#reports #ICUI

[ICU Medical](https://eninvs.com/all.php?name=ICUI) (Peripheral venous catheter producer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193273)
(2025-11-06, After Market Close):

- Revenue -8.8% YoY (vs -7.9% in previous quarter and historical rate +6.5%)
- EBITDA +1.6% YoY (vs -4.8% in previous quarter and historical rate +52.9%)
- EBITDA margin 12.1% increased compared to 10.9% same period last year
- Net Debt decreased by $24 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 6.5% of market cap
- EV/EBITDA multiple is 15.1x compared to historical level (75th percentile) of 23.9x
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-11-07

#reports #HQI

[HireQuest](https://eninvs.com/all.php?name=HQI) (Staffing and Employment Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193271)
(2025-11-06, After Market Close):

- Revenue -11.1% YoY (vs -11.1% in previous quarter and historical rate -3.0%)
- EBITDA margin 37.5% increased compared to -22.2% same period last year
- EV/EBITDA multiple is 11.9x compared to historical level (75th percentile) of 23.5x
- EV/Sales multiple is 3.8x

------------------------------------------------

2025-11-07

#reports #GOGO

[Gogo](https://eninvs.com/all.php?name=GOGO) (Telecom Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193262)
(2025-11-06, Before Market Open):

- Revenue +121.8% YoY (vs +121.6% in previous quarter and historical rate +21.7%)
- EBITDA +91.3% YoY (vs +96.2% in previous quarter and historical rate -2.9%)
- EBITDA margin 19.6% decreased compared to 22.8% same period last year
- Net Debt decreased by $34 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) -$0.3 bln (negative), 30.8% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 17.6x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went down -13.6% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #GMED

[Globus Medical](https://eninvs.com/all.php?name=GMED) (Medical equipment developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193261)
(2025-11-06, After Market Close):

- Revenue +22.8% YoY (vs +18.3% in previous quarter and historical rate +46.7%)
- EBITDA +80.9% YoY (vs +30.1% in previous quarter and historical rate +59.4%)
- EBITDA margin 27.0% increased compared to 18.4% same period last year
- Net Debt decreased by $163 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.6 bln (positive), 6.7% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 30.8x
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-11-07

#reports #FNKO

[Funko](https://eninvs.com/all.php?name=FNKO) (Vinyl figurine manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193256)
(2025-11-06, Before Market Open):

- Revenue -14.3% YoY (vs -22.2% in previous quarter and historical rate -11.2%)
- EBITDA -40.7% YoY (vs -174.1% in previous quarter and historical rate -18.9%)
- EBITDA margin 13.9% decreased compared to 20.1% same period last year
- Net Debt decreased by $9 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.4% of market cap
- EV/EBITDA multiple is 5.8x compared to historical level (75th percentile) of 35x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -0.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #FARM

[Farmer Bros](https://eninvs.com/all.php?name=FARM) (Packaged Foods) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193251)
(2025-11-06, After Market Close):

- Revenue -3.5% YoY (vs -66.8% in previous quarter and historical rate +1.7%)
- EBITDA margin -3.7% decreased compared to -3.5% same period last year
- Net Debt increased by $51 mln over the past reporting period (137.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 153.7% of market cap
- EV/EBITDA multiple is 5.9x compared to historical level (75th percentile) of 19.9x
- EV/Sales multiple is 0.3x

------------------------------------------------

2025-11-07

#reports #EVCM

[EverCommerce Inc.](https://eninvs.com/all.php?name=EVCM) (Software — Infrastructure) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193246)
(2025-11-06, After Market Close):

- Revenue -16.5% YoY (vs -16.4% in previous quarter and historical rate +1.6%)
- EBITDA +53.1% YoY (vs +10.3% in previous quarter and historical rate +24.5%)
- EBITDA margin 33.3% increased compared to 18.2% same period last year
- Net Debt increased by $43 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 24.6x
- EV/Sales multiple is 4.1x

------------------------------------------------

2025-11-07

#reports #ETON

[Eton Pharmaceuticals](https://eninvs.com/all.php?name=ETON) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193245)
(2025-11-06, After Market Close):

- Revenue +120% YoY (vs +111.1% in previous quarter and historical rate +86.3%)
- Net Debt decreased by $11 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0 bln (negative), 4.1% of market cap
- EV/EBITDA multiple is 254.4x compared to historical level (75th percentile) of 164.7x
- EV/Sales multiple is 7.3x

------------------------------------------------

2025-11-07

#reports #EPAM

[EPAM Systems](https://eninvs.com/all.php?name=EPAM) (Software developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193243)
(2025-11-06, Before Market Open):

- Revenue +19.3% YoY (vs +18.0% in previous quarter and historical rate +4.4%)
- EBITDA -0.5% YoY (vs -4.9% in previous quarter and historical rate -0.7%)
- EBITDA margin 14.1% decreased compared to 16.9% same period last year
- Net Debt decreased by $205 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$1 bln (negative), 10.6% of market cap
- EV/EBITDA multiple is 14.1x compared to historical level (75th percentile) of 21.5x
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +4.1% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #DOCS

[Doximity, Inc.](https://eninvs.com/all.php?name=DOCS) (Health Information Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193239)
(2025-11-06, After Market Close):

- Revenue +23.4% YoY (vs +15.0% in previous quarter and historical rate +17.3%)
- EBITDA +19.6% YoY (vs +16.3% in previous quarter and historical rate +28.4%)
- EBITDA margin 39.6% decreased compared to 40.9% same period last year
- Net Debt decreased by $38 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 42.1x compared to historical level (75th percentile) of 44.9x
- EV/Sales multiple is 17.5x

------------------------------------------------

2025-11-07

#reports #DIOD

[Diodes](https://eninvs.com/all.php?name=DIOD) ( Semiconductor manufacturer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193237)
(2025-11-06, After Market Close):

- Revenue +12% YoY (vs +14.4% in previous quarter and historical rate -8.6%)
- EBITDA -47.2% YoY (vs +15.0% in previous quarter and historical rate -32.4%)
- EBITDA margin 7.1% decreased compared to 15.1% same period last year
- Net Debt decreased by $54 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 16.4x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 1.5x

------------------------------------------------

2025-11-07

#reports #DH

[Definitive Healthcare Corp.](https://eninvs.com/all.php?name=DH) (Health Information Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193236)
(2025-11-06, After Market Close):

- Revenue -4.8% YoY (vs -4.7% in previous quarter and historical rate +5.9%)
- EBITDA margin -6.7% increased compared to -350.8% same period last year
- Net Debt decreased by $7 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 19.8% of market cap
- EV/Sales multiple is 1.7x

------------------------------------------------

2025-11-07

#reports #CPK

[Chesapeake Utilities Corporation](https://eninvs.com/all.php?name=CPK) (Utilities — Regulated Gas) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193231)
(2025-11-06, After Market Close):

- Revenue +12.5% YoY (vs +16.3% in previous quarter and historical rate +11.2%)
- EBITDA +17.2% YoY (vs +22.0% in previous quarter and historical rate +25.1%)
- EBITDA margin 37.8% increased compared to 36.3% same period last year
- Net Debt increased by $61 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.3% of market cap
- EV/EBITDA multiple is 14.2x compared to historical level (75th percentile) of 15.7x
- EV/Sales multiple is 5.3x

------------------------------------------------

2025-11-07

#reports #COLL

[Collegium Pharmaceutical](https://eninvs.com/all.php?name=COLL) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193229)
(2025-11-06, Before Market Open):

- Revenue +31.4% YoY (vs +29.7% in previous quarter and historical rate +36.1%)
- EBITDA +54.5% YoY (vs +10.8% in previous quarter and historical rate +78.1%)
- EBITDA margin 56.9% increased compared to 48.4% same period last year
- Net Debt decreased by $79 mln over the past reporting period (5.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 10.6% of market cap
- EV/EBITDA multiple is 5x compared to historical level (75th percentile) of 6.2x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went up +11.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #CERS

[Cerus](https://eninvs.com/all.php?name=CERS) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193223)
(2025-11-06, After Market Close):

- Revenue +15.2% YoY (vs +15.6% in previous quarter and historical rate +5.6%)
- EBITDA margin 3.8% increased compared to -2.2% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/Sales multiple is 1.4x

------------------------------------------------

2025-11-07

#reports #CENX

[Century Aluminum](https://eninvs.com/all.php?name=CENX) (Aluminum) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193222)
(2025-11-06, After Market Close):

- Revenue +17.3% YoY (vs +11.9% in previous quarter and historical rate -2.5%)
- EBITDA +5.3% YoY (vs +46.4% in previous quarter and historical rate +42.9%)
- EBITDA margin 15.7% decreased compared to 17.4% same period last year
- Net Debt decreased by $16 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 6.4% of market cap
- EV/EBITDA multiple is 11.5x compared to historical level (75th percentile) of 28.9x
- EV/Sales multiple is 1.3x

------------------------------------------------

2025-11-07

#reports #CE

[Celanese](https://eninvs.com/all.php?name=CE) (Chemicals manufacturer ) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=CE&q=2025 q3&id=896594)
(2025-10-31, Before Market Open):

- Revenue -8.6% YoY (vs -4.5% in previous quarter and historical rate +0.8%)
- EBITDA -351% YoY (vs -6.8% in previous quarter and historical rate -32.0%)
- EBITDA margin -44.9% decreased compared to 16.4% same period last year
- Net Debt decreased by $374 mln over the past reporting period (9.6% of market cap)
- FCF (LTM) +$0.8 bln (positive), 19.7% of market cap
- EV/Sales multiple is 1.7x

At the opening of the session the share price went down -0.4% vs S&P500 +0.8%

------------------------------------------------

2025-11-07

#reports #CDXS

[Codexis](https://eninvs.com/all.php?name=CDXS) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193221)
(2025-11-06, After Market Close):

- Revenue -30.8% YoY (vs +87.5% in previous quarter and historical rate -14.7%)
- EBITDA margin -200.0% decreased compared to -123.1% same period last year
- Net Debt increased by $7 mln over the past reporting period (5.3% of market cap)
- FCF (LTM) -$0 bln (negative), 10.5% of market cap
- EV/Sales multiple is 2.7x

------------------------------------------------

2025-11-07

#reports #CARS

[Cars.com](https://eninvs.com/all.php?name=CARS) (A digital marketplace of cars) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193217)
(2025-11-06, Before Market Open):

- Revenue +1.1% YoY (vs 0.0% in previous quarter and historical rate +3.8%)
- EBITDA -41% YoY (vs -37.8% in previous quarter and historical rate +12.6%)
- EBITDA margin 12.6% decreased compared to 21.7% same period last year
- Net Debt decreased by $32 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) +$0 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +0.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #CARG

[Cargurus](https://eninvs.com/all.php?name=CARG) (Vehicle retail) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193216)
(2025-11-06, After Market Close):

- Revenue +3.5% YoY (vs +6.8% in previous quarter and historical rate -14.9%)
- EBITDA +87.9% YoY (vs +3100.0% in previous quarter and historical rate +12.7%)
- EBITDA margin 25.9% increased compared to 14.3% same period last year
- Net Debt increased by $50 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.2 bln (positive), 4.8% of market cap
- EV/EBITDA multiple is 16x compared to historical level (75th percentile) of 30.7x
- EV/Sales multiple is 3.5x

------------------------------------------------

2025-11-07

#reports #BLMN

[Bloomin Brands](https://eninvs.com/all.php?name=BLMN) (Restaurants owner) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193213)
(2025-11-06, Before Market Open):

- Revenue -10.6% YoY (vs -10.5% in previous quarter and historical rate -2.9%)
- EBITDA -86.6% YoY (vs -22.9% in previous quarter and historical rate -28.5%)
- EBITDA margin 1.0% decreased compared to 6.4% same period last year
- Net Debt decreased by $16 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0 bln (negative), 6.1% of market cap
- EV/EBITDA multiple is 1.9x compared to historical level (75th percentile) of 3.1x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +8.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #BKD

[Brookdale Senior Living](https://eninvs.com/all.php?name=BKD) (Medical Care Facilities) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=BKD&q=2025 q3&id=896552)
(2025-11-06, After Market Close):

- Revenue +3.7% YoY (vs +4.5% in previous quarter and historical rate +5.3%)
- EBITDA +116.9% YoY (vs +0.9% in previous quarter and historical rate +32.8%)
- EBITDA margin 17.3% increased compared to 8.3% same period last year
- Net Debt decreased by $56 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) -$0.4 bln (negative), 23.1% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 15.4x
- EV/Sales multiple is 2.2x

------------------------------------------------

2025-11-07

#reports #BILL

[Bill.com](https://eninvs.com/all.php?name=BILL) (Software provider) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +10.6% YoY (vs -41.0% in previous quarter and historical rate +31.9%)
- EBITDA margin -3.0% decreased compared to -0.3% same period last year
- Net Debt increased by $647 mln over the past reporting period (14.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.3% of market cap
- EV/Sales multiple is 2.8x

------------------------------------------------

2025-11-07

#reports #BDX

[Becton Dickinson](https://eninvs.com/all.php?name=BDX) (Medical devices developer ) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=BDX&q=2025 q3&id=896482)
(2025-11-06, Before Market Open):

- Revenue +8.4% YoY (vs +10.4% in previous quarter and historical rate +5.1%)
- EBITDA +7.4% YoY (vs +28.2% in previous quarter and historical rate +1.1%)
- EBITDA margin 22.5% decreased compared to 22.7% same period last year
- Net Debt decreased by $52 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 13.8x compared to historical level (75th percentile) of 19x
- EV/Sales multiple is 3.2x

At the opening of the session the share price went down -6.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #ASPN

[Aspen Aerogels](https://eninvs.com/all.php?name=ASPN) (Building Products and Equipment) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193208)
(2025-11-06, Before Market Open):

- Revenue -37.6% YoY (vs -33.9% in previous quarter and historical rate +43.8%)
- EBITDA -90.9% YoY (vs -95.8% in previous quarter and historical rate +51.1%)
- EBITDA margin 2.7% decreased compared to 18.8% same period last year
- Net Debt decreased by $5 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.2 bln (positive), 58.3% of market cap
- EV/Sales multiple is 0.9x

At the opening of the session the share price went down -3.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #APD

[Air Products and Chemicals](https://eninvs.com/all.php?name=APD) ( Gases and chemicals producer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=APD&q=2025 q3&id=896361)
(2025-11-06, Before Market Open):

- Revenue -0.7% YoY (vs +1.2% in previous quarter and historical rate -1.5%)
- EBITDA -84.7% YoY (vs +8.6% in previous quarter and historical rate -5.9%)
- EBITDA margin 13.6% decreased compared to 88.0% same period last year
- Net Debt increased by $67 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$4 bln (negative), 6.9% of market cap
- EV/EBITDA multiple is 114.4x compared to historical level (75th percentile) of 20.5x
- EV/Sales multiple is 6.5x

At the opening of the session the share price went up +5.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #AMPH

[Amphastar Pharmaceuticals](https://eninvs.com/all.php?name=AMPH) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193203)
(2025-11-06, After Market Close):

- Revenue +0.5% YoY (vs -4.4% in previous quarter and historical rate +15.3%)
- EBITDA -47.6% YoY (vs -25.0% in previous quarter and historical rate +23.8%)
- EBITDA margin 17.2% decreased compared to 33.0% same period last year
- Net Debt decreased by $43 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) -$0 bln (negative), 4.0% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 2.1x

------------------------------------------------

2025-11-07

#reports #AMN

[AMN Healthcare Services](https://eninvs.com/all.php?name=AMN) (Health care workforce solutions provider ) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -7.8% YoY (vs -11.2% in previous quarter and historical rate -20.4%)
- EBITDA +38.5% YoY (vs -196.3% in previous quarter and historical rate -58.9%)
- EBITDA margin 14.2% increased compared to 9.4% same period last year
- Net Debt decreased by $81 mln over the past reporting period (11.4% of market cap)
- FCF (LTM) +$0.3 bln (positive), 35.5% of market cap
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-11-07

#reports #AKAM

[Akamai Technologies](https://eninvs.com/all.php?name=AKAM) (Network content provider) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +5% YoY (vs +6.4% in previous quarter and historical rate +4.8%)
- EBITDA +55.9% YoY (vs +1.0% in previous quarter and historical rate +3.3%)
- EBITDA margin 32.5% increased compared to 21.9% same period last year
- Net Debt decreased by $192 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0.7 bln (negative), 6.3% of market cap
- EV/EBITDA multiple is 11.3x compared to historical level (75th percentile) of 15.4x
- EV/Sales multiple is 3.6x

------------------------------------------------

2025-11-07

#reports #AAON

[AAON](https://eninvs.com/all.php?name=AAON) ( Heating equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193193)
(2025-11-06, Before Market Open):

- Revenue +17.4% YoY (vs -0.6% in previous quarter and historical rate +22.3%)
- EBITDA -22.9% YoY (vs -46.3% in previous quarter and historical rate +38.2%)
- EBITDA margin 16.7% decreased compared to 25.4% same period last year
- Net Debt increased by $42 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.2 bln (negative), 2.8% of market cap
- EV/EBITDA multiple is 40.8x compared to historical level (75th percentile) of 32x
- EV/Sales multiple is 6.5x

At the opening of the session the share price went up +17.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #DBX
@ saas

[Dropbox](https://eninvs.com/all.php?name=DBX) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=DBX&q=2025 q3&id=896698)
(2025-11-06, After Market Close):

- Revenue -0.8% YoY (vs -1.4% in previous quarter and historical rate +3.4%)
- EBITDA +31.3% YoY (vs +30.2% in previous quarter and historical rate +20.4%)
- EBITDA margin 33.8% increased compared to 25.5% same period last year
- Net Debt increased by $240 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0.5 bln (positive), 4.2% of market cap
- EV/EBITDA multiple is 17x compared to historical level (75th percentile) of 31.8x
- EV/Sales multiple is 5.2x

------------------------------------------------

2025-11-07

#reports #BL
@ saas

[Blackline](https://eninvs.com/all.php?name=BL) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=BL&q=2025 q3&id=896554)
(2025-11-06, After Market Close):

- Revenue +7.2% YoY (vs +6.8% in previous quarter and historical rate +11.5%)
- EBITDA -8.3% YoY (vs +83.3% in previous quarter and historical rate +97.2%)
- EBITDA margin 6.2% decreased compared to 7.2% same period last year
- Net Debt increased by $55 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0.8 bln (negative), 24.0% of market cap
- EV/EBITDA multiple is 94.2x compared to historical level (75th percentile) of 142.4x
- EV/Sales multiple is 5.2x

------------------------------------------------

2025-11-07

#reports #APPN
@ saas

[Appian](https://eninvs.com/all.php?name=APPN) (Business Automation Platform) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193204)
(2025-11-06, Before Market Open):

- Revenue +21.4% YoY (vs +17.1% in previous quarter and historical rate +31.1%)
- EBITDA margin 6.4% increased compared to -5.2% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.0% of market cap
- EV/Sales multiple is 2.6x

At the opening of the session the share price went up +9.1% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #OUT
@ REITs

[Outfront Media (REIT)](https://eninvs.com/all.php?name=OUT) (REIT — Specialty) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +3.5% YoY (vs -3.6% in previous quarter and historical rate +1.4%)
- EBITDA -22.2% YoY (vs -67.7% in previous quarter and historical rate +9.8%)
- EBITDA margin 23.9% decreased compared to 31.9% same period last year
- Net Debt increased by $13 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 19.6x compared to historical level (75th percentile) of 16.6x
- EV/Sales multiple is 3.9x

------------------------------------------------

2025-11-07

#reports #LAMR
@ REITs

[Lamar Advertising](https://eninvs.com/all.php?name=LAMR) (REIT — Specialty) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193282)
(2025-11-06, Before Market Open):

- Revenue +3.9% YoY (vs +2.5% in previous quarter and historical rate +20.1%)
- EBITDA +5% YoY (vs +5.7% in previous quarter and historical rate +35.2%)
- EBITDA margin 46.9% increased compared to 46.5% same period last year
- Net Debt increased by $34 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.1% of market cap
- EV/EBITDA multiple is 10.4x compared to historical level (75th percentile) of 13.9x
- EV/Sales multiple is 3.7x

At the opening of the session the share price went down -0.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #GEO
@ REITs

[The GEO Group](https://eninvs.com/all.php?name=GEO) (REIT — Healthcare Facilities) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193259)
(2025-11-06, Before Market Open):

- Revenue +13.1% YoY (vs +4.8% in previous quarter and historical rate +3.2%)
- EBITDA -35.1% YoY (vs -5.4% in previous quarter and historical rate -9.2%)
- EBITDA margin 10.9% decreased compared to 18.9% same period last year
- Net Debt decreased by $270 mln over the past reporting period (12.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 9.6x compared to historical level (75th percentile) of 11.2x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +3.7% vs S&P500 -0.4%

Switch to company model in "Rising Stars" logic    *